NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 119-127

  Liu, Ming Fa ^a   Jin, Tao ^a   Shen, Jin Hui ^a   Shen, Zhong Ying ^b   Zheng, Zhi Chao ^c   Zhang, Zeng Liang ^c   Xu, Li Yan ^b   Li, En Min ^b   Xu, Hai Xiong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Brain tumor; Gliomas; Immunohistochemistry; NGAL; NGALR; Prognosis

Indexed keywords

CELL RECEPTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MIDDLE AGED; ORGANIC CATION TRANSPORT PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 80052765913     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0486-0     Document Type: Article

References (27)

1. DN Louis H Ohgaki OD Wiestler, et al. 2007 The 2007 WHO classifcation of tumours of the central nervous system Acta Neuropathol 114 97 109 17618441 10.1007/s00401-007-0243-4 (Pubitemid 47103521)
2. LM Deangelis 2001 Brain tumors N Engl J Med 344 114 123 11150363 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D (Pubitemid 32052502)
3. DR Flower 1996 The lipocalin protein family: structure and function Biochem J 318 1 14 8761444 1:CAS:528:DyaK28XltlKrtLc%3D (Pubitemid 26283618)
4. DH Goetz MA Holmes N Borregaard ME Bluhm KN Raymond RK Strong 2002 The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Mol Cell 10 1033 1043 12453412 10.1016/S1097-2765(02)00708-6 1:CAS:528:DC%2BD38Xptl2ksLk%3D (Pubitemid 36001971)
5. J Yang D Goetz JY Li, et al. 2002 An iron delivery pathway mediated by a lipocalin Mol Cell 10 1045 1056 12453413 10.1016/S1097-2765(02)00710-4 1:CAS:528:DC%2BD38Xptl2ksLY%3D (Pubitemid 35453824)
6. D Bolignano V Donato A Lacquaniti, et al. 2010 Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene Cancer Lett 288 10 16 19540040 10.1016/j.canlet.2009.05.027 1:CAS:528:DC%2BC3cXnvFygtA%3D%3D
7. S Xu P Venge 2000 Lipocalins as biochemical markers of disease Biochim Biophys Acta 1482 298 307 11058770 10.1016/S0167-4838(00)00163-1 1:CAS:528:DC%2BD3MXotFKh
8. LR Devireddy C Gazin X Zhu MR Green 2005 A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake Cell 123 1293 1305 16377569 10.1016/j.cell.2005.10.027 1:CAS:528:DC%2BD28XktlWiug%3D%3D (Pubitemid 41821786)
9. DR Richardson 2005 Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer Curr Med Chem 12 2711 2729 16305467 10.2174/092986705774462996 1:CAS:528:DC%2BD2MXht1ShsrrL (Pubitemid 41601569)
10. J Kaplan 2002 Mechanisms of cellular iron acquisition: another iron in the fire Cell 111 603 606 12464171 10.1016/S0092-8674(02)01164-9 1:CAS:528:DC%2BD38XptlGrtb4%3D (Pubitemid 35441241)
11. YC Hung GS Huang LW Lin MY Hong PS Se 2007 Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice Food Chem Toxicol 45 1123 1130 17303299 10.1016/j.fct.2006.12.017 1:CAS:528:DC%2BD2sXksV2qtrg%3D (Pubitemid 46590553)
12. K Mori HT Lee D Rapoport, et al. 2005 Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury J Clin Invest 115 610 621 15711640 1:CAS:528:DC%2BD2MXit1emsbc%3D (Pubitemid 40322235)
13. M Bauer JC Eickhoff MN Gould C Mundhenke N Maass A Friedl 2008 Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer Breast Cancer Res Treat 108 389 397 17554627 10.1007/s10549-007-9619-3 1:CAS:528:DC%2BD1cXjsFGisb0%3D (Pubitemid 351431077)
14. A Iannetti F Pacifico R Acquaviva, et al. 2008 The neutrophil gelatinase-associated lipocalin(NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells Proc Natl Acad Sci USA 105 14058 14063 18768801 10.1073/pnas.0710846105 1:CAS:528:DC%2BD1cXhtFKiurvE
15. FJ Kubben CF Sier LJ Hawinkels, et al. 2007 Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer Eur J Cancer 43 1869 1876 17604154 10.1016/j.ejca.2007.05.013 1:CAS:528:DC%2BD2sXovFGntLw%3D (Pubitemid 47238246)
16. H Zhang L Xu D Xiao, et al. 2007 Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion J Clin Pathol 60 555 561 17412867 10.1136/jcp.2006.039297 1:CAS:528: DC%2BD2sXnt1Gku7w%3D (Pubitemid 46867169)
17. L Cui LY Xu ZY Shen, et al. 2008 NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma Clin Cancer Res 14 7674 7681 19047093 10.1158/1078-0432.CCR-08-0420 1:CAS:528:DC%2BD1cXhsVegtrbN
18. WK Fang LY Xu XF Lu, et al. 2007 A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells Biochem J 403 297 303 17253959 10.1042/BJ20060836 1:CAS:528: DC%2BD2sXjsVWrt7s%3D (Pubitemid 46596586)
19. M Hutterer P Knyazev A Abate, et al. 2008 Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme Clin Cancer Res 14 130 138 18172262 10.1158/1078-0432.CCR-07-0862 1:CAS:528:DC%2BD1cXoslCn (Pubitemid 351377987)
20. W Remmele KH Schicketanz 1993 Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) versus subjective grading (IRS) Pathol Res Pract 189 862 866 8302707 1:STN:280:DyaK2c7jsVGntA%3D%3D (Pubitemid 23308006)
21. T Bratt 2000 Lipocalins and cancer Biochim Biophys Acta 1482 318 326 11058772 10.1016/S0167-4838(00)00154-0 1:CAS:528:DC%2BD3MXotFKn
22. Z Sheng SZ Wang MR Green 2009 Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R EMBO J 28 866 876 19229297 10.1038/emboj.2009.35 1:CAS:528:DC%2BD1MXitFKlsb0%3D
23. D Bolignano V Donato G Coppolino, et al. 2008 Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage Am J Kidney Dis 52 595 605 18725016 10.1053/j.ajkd.2008.01.020 1:CAS:528:DC%2BD1cXhtFOrt73K
24. P Devarajan 2008 NGAL in acute kidney injury: from serendipity to utility Am J Kidney Dis 52 395 399 18725011 10.1053/j.ajkd.2008.07.008
25. SP Stoesz A Friedl JD Haag MJ Lindstrom GM Clark MN Gould 1998 Heterogeneous expression of the lipocalin NGAL in primary breast cancers Int J Cancer 79 565 572 9842963 10.1002/(SICI)1097-0215(19981218)79:6<565::AID- IJC3>3.0.CO;2-F 1:CAS:528:DyaK1MXktVQ%3D (Pubitemid 28549466)
26. ER Smith M Manfredi RM Scott PM Black MA Moses 2007 A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report Neurosurgery 60 E1148 E1149 17538362 10.1227/01.NEU.0000255464.37634.3C (Discussion E1149) (Pubitemid 46849869)
27. ER Smith D Zurakowski A Saad RM Scott MA Moses 2008 Urinary biomarkers predict brain tumor presence and response to therapy Clin Cancer Res 14 2378 2386 18413828 10.1158/1078-0432.CCR-07-1253 1:CAS:528:DC%2BD1cXkvFGmtbw%3D (Pubitemid 351551071)